Fierce Pharma
AUGUST 14, 2024
With an FDA appro | The FDA has approved Gilead's primary biliary cholangitis treatment Livdelzi. The drug, which was acquired in a $4.3 billion buyout of CymaBay Therapeutics six months ago, is the first inflammatory treatment launched by Gilead.
MedCity News
AUGUST 14, 2024
Pharmacists and pharmacy technicians at a Walgreens store in Vancouver, Washington, have filed a petition to join the Pharmacy Guild. The workers argued that they are facing heavy workloads and inadequate staffing. The post First Walgreens Store Files to Unionize with the Pharmacy Guild appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
AUGUST 14, 2024
Johnson & Johnson and Roche are at the top of S&P Global’s pharmaceutical industry power ratings, which assess the strength of the world’s top 17 drugmakers. | Johnson & Johnson and Roche are at the top of S&P Global’s pharmaceutical industry power ratings, which assess the strength of the world’s top 17 drugmakers.
MedCity News
AUGUST 14, 2024
Livdelzi is now FDA-approved for treating the rare liver disease primary biliary cholangitis. Gilead Sciences added the drug to its pipeline via the $4.3 billion acquisition of CymaBay Therapeutics earlier this year. The post FDA Awards Accelerated Approval to Gilead Sciences Drug for Rare Liver Disease appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
AUGUST 14, 2024
Bluebird Bio is making progress on the launch of its three approved gene therapies but appears to be trailing Vertex in its competition to attract patients to their respective treatments for sickle | Bluebird Bio is making progress on the launch of its three approved gene therapies but appears to be trailing Vertex in competition to attract patients to their respective treatments for sickle cell disease.
MedCity News
AUGUST 14, 2024
Six months after Change Healthcare suffered its cyberattack, some health systems are still missing payments for patient encounters from February, according to a new report. It showed that small hospitals are still missing about 3-5% of expected net revenue for patient encounters from February. The post Health Systems Are Still Missing Payments Because of the Change Healthcare Cyberattack appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
AUGUST 14, 2024
Next-generation robotic platforms have made a significant leap forward with real-time data analysis and intraoperative feedback, instilling a new confidence in surgical decisions while helping to minimize the potential for error during surgery. The post The Future of Robotic Surgery: Leading the Way with Digital Solutions appeared first on MedCity News.
pharmaphorum
AUGUST 14, 2024
Otsuka and Click Therapeutics' first-in-class prescription digital therapeutic for depression launches in US through mobile app stores
MedCity News
AUGUST 14, 2024
Current trends are driven by various strategic and financial considerations from both established pharmaceutical companies and development-stage biotech firms. Understanding the valuation and accounting implications of these transactions are crucial for stakeholders to navigate the complex landscape effectively. The post Valuation of Biotech Transactions: Trends, Drivers, and Implications appeared first on MedCity News.
PharmaTimes
AUGUST 14, 2024
Heart failure with preserved ejection fraction makes up 50% of all UK heart failure cases
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
AUGUST 14, 2024
Baxter International has agreed to sell its kidney treatment division to private equity firm Carlyle Group in a $3.8 billion cash deal, continuing its efforts to streamline its operations and reduce debt.
Pharmaceutical Commerce
AUGUST 14, 2024
The latest news for pharma industry insiders.
pharmaphorum
AUGUST 14, 2024
Firefly Neuroscience lists on Nasdaq via a $45m merger with IT firm WaveDancer, as it rolls out an AI-powered platform for managing brain function.
Pharmaceutical Commerce
AUGUST 14, 2024
In this part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ Senior Director of DSCSA/Serialization Compliance Services, describes the outcome of the joint public meeting held by the Partnership for DSCSA Governance and the FDA.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
pharmaphorum
AUGUST 14, 2024
AstraZeneca has claimed the first regulatory approval for an immunotherapy/PARP inhibitor combination for endometrial cancer.
Pharma IQ
AUGUST 14, 2024
Discover how Otsuka and Oxford HIN are collaborating to evaluate and implement CARE for MDD, a digital therapeutic designed to treat major depressive disorder.
pharmaphorum
AUGUST 14, 2024
The rapid spread of a new variant of mpox – previously known as monkeypox – has prompted the Africa Centers for Disease Control and Prevention (Africa CDC) to declare a public health emergency.
Pharmaceutical Technology
AUGUST 14, 2024
AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan), has received conditional approval in China for gastric cancer.
PharmaTimes
AUGUST 14, 2024
The findings could improve cancer treatment and drug delivery to treat tumours
PharmaTech
AUGUST 14, 2024
AstraZeneca and Daiichi Sankyo first entered into an agreement to develop Enhertu in March 2019, and the antibody-drug conjugate has since been approved for various groups in more than 65 countries.
PharmaVoice
AUGUST 14, 2024
The German biotech is leveraging its mRNA platforms to develop a new class of cancer treatments that are necessary to lift the company’s flagging sales.
Pharmacy Times
AUGUST 14, 2024
The seroprotection rate of antibody titers was 100% against the 3 viruses, and geometric mean titer also increased from administration to day 43.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Clarify Health
AUGUST 14, 2024
Today’s h ealthcare providers face significant challenges that can impede their ability to deliver consistent, high-quality care. Fragmented and siloed care, inefficiencies and high operational costs, poor patient satisfaction, complicated chronic conditions, challenges to achieving value-based care metrics, a lack of insight into market insights, and inadequate patient follow-up care all present barriers to providing a holisti c patient journey and implementing strategic growth opportunities fo
Pharmacy Times
AUGUST 14, 2024
Individuals with Parkinson disease reported a decrease in bacterial genes for biosynthesis of riboflavin (vitamin B2) and biotin (vitamin B7).
Evolve Your Success
AUGUST 14, 2024
Episode Description Unlock the secrets to harmonizing marketing and sales in the medical industry with Terrence Wiggins, the Global Marketing Director at Cook Medical. Discover how leveraging diverse marketing channels—from social media to promotional events—can catapult brand awareness and product success. Terrence demystifies the often-contentious relationship between sales and marketing, offering actionable tips for aligning these teams to achieve shared goals and maximize impact.
Pharmacy Times
AUGUST 14, 2024
In recent years, telestroke services have transformed stroke care delivery, especially in rural or underserved areas.
PM360
AUGUST 14, 2024
Designed To Support Patient Engagement And Improve Access To Medication Information Woburn, MA – August 8, 2024 – MedAdvisor Solutions, the global leader of pharmacy-driven patient engagement solutions, and Brand Engagement Network (BEN) , a provider of safe, personalized customer engagement AI, today announced that the companies’ revolutionary AI-driven medication advisor will be available for live demonstration at the 2024 National Association of Chain Drug Stores – Total Store Expo ( NAC
Pharmacy Times
AUGUST 14, 2024
The decision is based on clinical findings demonstrating seladelpar’s ability to effectively regulate of alkaline phosphatase values in patients.
Pharmaceutical Technology
AUGUST 14, 2024
IGNYTE-3 is a Phase III trial investigating Replimune’s flagship oncolytic treatment for advanced, treatment-resistant melanoma.
Pharmacy Times
AUGUST 14, 2024
The data builds off prior studies supporting bendamustine-rituximab as a first-line treatment for patients with non-Hodgkin lymphoma.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
344 
Let's personalize your content